HomeOpen Access NewsOptical Health

Optical Health

Switching to faricimab for patients with diabetic macular oedema

A recent study, published in the journal Nature looked into the six-month impact of switching neovascular age-related macular degeneration and diabetic macular oedema patients to faricimab instead of anti-VEGF therapy.

How can biomaterials-based technologies treat vision disorders?

Professor Heather Sheardown, leader of Innovation Hub C20/20, discusses their research, innovation, and development of new biomaterials-based technologies to treat a variety of disorders in the eye.

Understanding the connection between vision loss and mental health

Victoria Johnson from Vision Loss Rehabilitation Canada sheds light on the connection between vision loss and mental health.

The silence before the tsunami: COVID is devastating behind NHS virus frontlines

Doctor Allon Barsam, consultant eye surgeon and founder of Ophthalmic Consultants of London, calls attention to the unexplored devastation behind the NHS virus frontlines.

Seeing the way forward for eye care in the UK

Debbie McGill, Head of Policy and Public Affairs at the Association of British Dispensing Opticians, tells us all we need to know on accessing eye care and the leading causes of sight loss in the UK.

Caring for your eyes whilst working from home

Roshni Patel, optometrist at Lenstore, highlights three key areas you need to address to make sure you’re caring for your eyes in the best way possible whilst working from home.

World Glaucoma Week: The importance of eye examinations

In recognition of World Glaucoma Week, The Association of British Dispensing Opticians (ABDO) highlights how a simple eye test is a key way to detect Glaucoma.

World Glaucoma Week 2020: A guide for contact lens wearers

As part of World Glaucoma Week, Alastair Lockwood, ophthalmologist and eye health specialist at Feel Good Contacts, explains how to minimise the risks of developing glaucoma in later life, and for lens wearers, how to ensure you are wearing them most effectively.

Eye health: Testing the safety of stem cell therapy for age-related macular degeneration

Kapil Bharti, PhD, Senior Investigator and Head of the Ocular and Stem Cell Translational Research Section at the National Eye Institute (NEI), explains testing the safety of a stem cell therapy for age-related macular degeneration in this special focus on eye health.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders